Search for: "Tom Lamb"
Results 121 - 140
of 1,048
Sorted by Relevance
|
Sort by Date
8 May 2008, 8:58 am
Women Have Developed Serious Side Effects Like Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) After Using This Birth Control Patch (Posted by Tom Lamb at DrugInjuryWatch.com) On May 8, 2008 Public Citizen's Health Research Group (HRG) sent its "Petition to the FDA to Ban Ortho-Evra" to Commissioner Andrew von Eschenbach. [read post]
27 Jul 2009, 12:35 pm
Requests Consolidation Of Federal Court Lawsuits Alleging Yasmin Or YAZ Caused Injury Such As Stroke, Heart Attack, Pulmonary Thrombosis, Deep Vein Thrombosis, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ Update: According to a Notice of Hearing Session issued August 14, 2009 by the U.S. [read post]
Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills
17 Feb 2012, 12:52 pm
Same General Warning About All COCs Was Added To YAZ In March 2011; And Why The One Year Delay, We Wonder (Posted by Tom Lamb at DrugInjuryWatch.com) The February 14, 2012 email captioned "What's New on the FDA Drugs Site" let us know that there was a new version of the Package Insert for Yasmin, Safyral, and Beyaz which consisted of four new sentences being added to the WARNINGS AND PRECAUTIONS section: 5.1 Thromboembolic Disorders and Other Vascular Problems… [read post]
26 Sep 2008, 7:23 pm
Goodwin Will Preside Over "Double-Dose" Digitek Pill Cases Pursuant To MDL Litigation Order (Posted by Tom Lamb at DrugInjuryWatch.com) On August 13, 2008 the Judicial Panel on Multidistrict Litigation (JPMDL) issued an order creating the Digitek products liability multidistrict litigation, In Re: Digitek Products Liability Litigation, MDL No. 1968, JPMDL. [read post]
11 Jan 2008, 7:32 am
Blumsohn Shines His Bright Light On This Troubling Situation And Provides A Lengthy List Of Recent Blog Posts About Zetia And Vytorin (Posted by Tom Lamb at DrugInjuryWatch.com) Over at the Scientific Misconduct Blog, Dr. [read post]
17 Apr 2007, 10:46 am
Amgen-Sponsored Study Was Testing Aranesp In Cancer Patients Who Developed Anemia (Posted by Tom Lamb at DrugInjuryWatch.com) An April 17, 2007 Wall Street Journal (WSJ) article about the results of a new study concerning Aranesp revealed more bad news for Amgen Inc., the maker of this anemia drug:Amgen's drug Aranesp didn't reduce the need for blood transfusions in anemic cancer patients and was linked to a nearly 45% increase in deaths compared with patients taking a… [read post]
24 Sep 2009, 1:09 pm
Medical Journal Article Points To Imbalance Between Bone Resorption And Bone Formation At Affected Bone (Posted by Tom Lamb at DrugInjuryWatch.com) In the October 2009 edition of the Journal of Bone and Mineral Research we found an article which advances the epidemiology of bisphosphonate-related femur fractures. [read post]
16 Jan 2008, 11:37 am
Public Workshop On January 29, 2008 To Focus On Adverse Drug Reaction Reporting (Posted by Tom Lamb at DrugInjuryWatch.com) In recent years the FDA has been roundly criticized for its failure to timely recognize emerging drug safety issues. [read post]
28 Aug 2007, 3:36 pm
Organon's Contraceptive Vaginal Ring Uses Etonogestrel, A Metabolite Of Dangerous Progestin Desogestrel (Posted by Tom Lamb at DrugInjuryWatch.com) NuvaRing is a contraceptive vaginal ring that was approved by the FDA in October 2001. [read post]
17 Nov 2008, 10:37 pm
Levine's Drug Injury Situation (Posted by Tom Lamb at DrugInjuryWatch.com) I received an email earlier this afternoon from Kyle Murphy, Communications Specialist for the Alliance for Justice (AFJ), in Washington, D.C., that informed me about two items concerning Diana Levine -- named plaintiff in the relatively well-known Wyeth v. [read post]
16 May 2008, 7:30 am
Six Months After It Announced Start Of This Investigation, FDA Gives An Update On Status Of Maxipime Safety Review (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-November 2007 the FDA announced the start of its investigation into the safety of Maxipime (cefepime), and said their safety evaluation should take about four months to complete. [read post]
1 Dec 2010, 1:55 pm
MHRA Warns UK Doctors To Monitor Cancer Patients For ONJ Where There Is Concomitant Use Of These Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) On November 30, 2010 the Medicines and Healthcare products Regulatory Agency (MHRA) issued two new safety warnings to doctors and other healthcare providers in the UK concerning the cancer drugs Avastin and Sutent. [read post]
17 Oct 2008, 12:54 pm
Company Will Pay $745 Million In Settlements To Conclude 90% Of These Lawsuits (Posted by Tom Lamb at DrugInjuryWatch.com) An October 17, 2008 Wall Street Journal (WSJ) article, "Pfizer to Settle Celebrex and Bextra Suits", broke the news and provided the details: Pfizer Inc. has agreed in principle to pay $894 million to settle litigation related to its painkillers Celebrex and Bextra. [read post]
22 Jul 2009, 2:45 pm
July 2009 Pediatrics Medical Journal Article Finds Most Cases Involved Infants Less Than One Year Of Age (Posted by Tom Lamb at DrugInjuryWatch.com) The article "Cardiovascular Medication Errors in Children" was published in the July 2009 edition of the medical journal Pediatrics. [read post]
26 Aug 2008, 5:51 pm
Ruling By Judicial Panel on Multidistrict Litigation Will Result In Transfer Of All NuvaRing Federal Court Cases (Posted by Tom Lamb at DrugInjuryWatch.com) On August 22, 2008 the Judicial Panel on Multidistrict Litigation (JPMDL) granted a petition filed by plaintiffs in 11 NuvaRing federal court lawsuits seeking creation of a NuvaRing multidistrict litigation (MDL). [read post]
2 Oct 2008, 7:54 pm
September 2008 Dear Doctor Letter From Pfizer Follows 2007 EMEA Safety Review Of Cabergoline (Posted by Tom Lamb at DrugInjuryWatch.com) Pfizer's Dostinex (cabergoline) remains on the market despite the January 2007 reports in the New England Journal of Medicine that Dostinex, like Permax, was linked to valvular heart disease. [read post]
27 Mar 2009, 12:39 pm
The Pharm Tech Blog Presents A Top 50 List Which Includes Many Fine Pharma Sites, And Drug Injury Watch (Posted by Tom Lamb at DrugInjuryWatch.com) Earlier this week I learned that the Drug Injury Watch blog -- which I started in April 2005 -- was listed as one of "The Top 50 Pharmaceutical News and Research Blogs" by The Pharm Tech Blog. [read post]
5 Nov 2010, 1:14 pm
Cases Of Interstitial Lung Disease (ILD) And Rhabdomyolysis / Myopathy Associated With Cholesterol Drugs Known As Statins, Including Zocor (Posted by Tom Lamb at DrugInjuryWatch.com) The October 2010 issue of the Canadian Adverse Reaction Newsletter (CARN) included an article "Statins and interstitial lung disease" which began with these two "Key points": During the last 15 years, 29 cases of interstitial lung disease (ILD) suspected of being… [read post]
14 Feb 2008, 2:44 pm
January 2008 Health Canada Newsletter Presents These Adverse Reaction Cases, And Announces "Canada Vigilance" (Posted by Tom Lamb at DrugInjuryWatch.com) The Canadian Adverse Reaction Newsletter (CARN), in its January 2008 edition (Volume 18, Issue 1), has two articles of interest regarding side effects associated with birth control products that are alternatives to oral contraceptives. [read post]
25 Nov 2008, 6:45 pm
One May Start There, But Be Sure To Check More Comprehensive Online Sites Such As MedlinePlus.gov And Medscape.com (Posted by Tom Lamb at DrugInjuryWatch.com) A November 25, 2008 Reuters Health article, "Wikipedia often omits important drug information: study", by reporter Anne Harding, had this precautionary advice for people who are are looking for information about their prescription drugs or over-the-counter medications: Consumers who… [read post]
